Welspun World Honors Republic Day with a Moving Tribute to Inclusivity and Unity
Neel Achary business
Welspun World Honors Republic Day with a Moving Tribute to Inclusivity and Unity

Mumbai, January 24, 2025: In a heartfelt celebration of the 76th Republic Day, Welspun World unveiled a unique video featuring its deaf and hard-of-hearing employees performing India’s National Song, Vande Mataram, through vibrations, touch, and sign language. The video stands as a compelling illustration to Welspun’s relentless commitment to inclusivity and empathy, reflecting the company’s […]

The post Welspun World Honors Republic Day with a Moving Tribute to Inclusivity and Unity first appeared on Business News Week.

Arena Animation Hosts Special Webinar for 5000+ Students on the Making of Kalki 2898 AD
Neel Achary business
Arena Animation Hosts Special Webinar for 5000+ Students on the Making of Kalki 2898 AD

Mumbai, 24 January 2025: Arena Animation, one of India’s leading animation institutes and a training brand of Aptech Limited, organised a special webinar for its students, giving them an exclusive and in-depth access into the making of the popular fantasy film Kalki 2898 AD. Over 5000 students from Arena Animation’s centres across India attended the […]

The post Arena Animation Hosts Special Webinar for 5000+ Students on the Making of Kalki 2898 AD first appeared on Business News Week.

5 Must-Watch Patriotism Stories: From ‘Secret Fauji’ to ‘Sky Force’ This Republic Day
Neel Achary business
5 Must-Watch Patriotism Stories: From ‘Secret Fauji’ to ‘Sky Force’ This Republic Day

Republic Day is more than parades and patriotic songs; it’s a moment to honor the bravery, sacrifice, and unwavering spirit of those who protect our nation. What better way to immerse yourself in their world than through gripping stories of valor, action, and resilience? From high-stakes battlefield dramas to intelligence thrillers, these five titles capture […]

The post 5 Must-Watch Patriotism Stories: From ‘Secret Fauji’ to ‘Sky Force’ This Republic Day first appeared on Business News Week.

Ather Energy Rolls Out Multi-Language Dashboard for Indian Consumers
Neel Achary business
Ather Energy Rolls Out Multi-Language Dashboard for Indian Consumers

New Delhi, 24 January 2025: Ather Energy Limited, one of India’s electric two-wheeler manufacturers, has launched a multi-language dashboard interface for its family scooter, Rizta. The scooter’s dashboard will now support 8 regional languages – Hindi, Marathi, Gujarati, Bengali, Tamil, Telugu, Malayalam, and Kannada, making it more accessible to a wider audience and enhancing the […]

The post Ather Energy Rolls Out Multi-Language Dashboard for Indian Consumers first appeared on Business News Week.

Syngene Reports Strong Results for Third Quarter
Neel Achary business
Syngene Reports Strong Results for Third Quarter

Mumbai, January 24, 2025: Syngene International Limited today announced its third quarter financial results. Reported revenue from operations was up by 11% year-on-year to Rs. 944 crores and increased sequentially by 6% from the prior quarter. Reported profit after tax, after exceptional items, was up 18% year-on-year to Rs. 131 crores. Commenting on the quarter, […]

The post Syngene Reports Strong Results for Third Quarter first appeared on Business News Week.

Sugee Group and MCA Celebrate 50 Glorious Years of Wankhede Stadium
Rutuparna Rath news
Sugee Group and MCA Celebrate 50 Glorious Years of Wankhede Stadium

Mumbai, January 24, 2025: The Wankhede Stadium, a cornerstone of Indian cricket history, came alive with emotion, nostalgia, and celebration as the Mumbai Cricket Association (MCA) marked its 50th anniversary on January 19, 2025. The iconic venue hosted a grand spectacle, presented by Sugee Group as the Title Sponsor, celebrating five decades of cricketing excellence.

The mesmerizing evening, hosted by Mandira Bedi, Prasanna Sant, and Jatin Sapru, featured captivating performances by renowned artists Avadhoot Gupte and Ajay-Atul, along with a spectacular laser show, offering an unforgettable experience for the audience.

Established in 1974, the iconic stadium has witnessed numerous historic cricketing moments, etching its name firmly in modern cricket history. The event brought together cricket legends across generations, including Sunil Gavaskar, Sachin Tendulkar, Rohit Sharma, Ravi Shastri, Ajinkya Rahane, Diana Edulji, Shreyas Iyer, Yashasvi Jaiswal among others. Fans experienced heartfelt moments, a magnificent tribute to Wankhede’s illustrious legacy, and an inspiring vision of hope for the future of Indian cricket.

Cricketing legends and captains, past and present, echoed their sentiments, while groundsmen and support staff were honoured. All echoed the significance the stadium has had in shaping their career and India’s overall cricketing journey. The essence of Mumbai’s cricketing legacy which produces talented players year-on-year, also came to the forefront in deliberations among the star players.

Sugee Group Founder and Managing Partner, Mr. Nishant Deshmukh, expressed immense pride in partnering with MCA for this milestone celebration, stating, “Wankhede Stadium is not just a landmark; it is the soul of Mumbai’s cricketing passion and a living embodiment of the city’s rich cultural heritage. To be part of such a historic occasion is a moment of immense honour and deep gratitude for Sugee Group. This celebration resonates with our core values of enriching lives, preserving legacies, and fostering connections that transcend time. Contributing to this iconic event was a heartfelt tribute to Mumbai’s spirit and the timeless memories it creates for generations.”

MCA President Shri Ajinkya Naik added, “The support of Sugee Group as our Title Sponsor elevated the grandeur of this celebration. Their dedication to Mumbai’s development complements the spirit of Wankhede Stadium, and together, we delivered an unforgettable experience to cricket enthusiasts across the nation.”

Skillsvarsity Launches 2nd Directorship Program for Women
Bhumika Lenka business
Skillsvarsity Launches 2nd Directorship Program for Women

Talent Skillsvarsity – A leading Skills & Education company announced the introduction of the 2nd cohort of an Exclusive Women Founders Directorship Program in partnership with the Confederation of Indian Industry (CII) to empower women entrepreneurs for leadership roles in corporate governance.

The program will be held on February 14th, 15th, and 20th, 2025, in Mumbai and is designed as an invite-only event for a select group of accomplished women founders.

This groundbreaking program aims to address the gender gap in boardrooms by equipping women entrepreneurs with essential knowledge and skills to excel as board directors. The sessions will cover key areas, including:

  • Roles and Responsibilities of Board Directors
  • Corporate Governance Best Practices
  • Financial Oversight and Compliance
  • Strategic Decision-Making

The Women Founders Directorship Program will feature renowned experts and industry leaders who will guide participants through interactive workshops, case studies, and networking opportunities. By fostering a deeper understanding of boardroom dynamics, the program seeks to prepare women founders for impactful contributions in leadership and governance.

Speaking on the initiative, Ambarish Datta, Founder and CEO of Talent Skillsvarsity, said, “This program is a step towards bridging the leadership gap and creating a future where women leaders thrive in corporate boardrooms. This also assists founders to set up their own board or use their skills to become an Independent Director in other company boards. We are committed to empowering women entrepreneurs to take on impactful leadership roles in governance”

The exclusive, invite-only nature of the program ensures that participants will be part of an elite cohort, fostering an environment of shared learning and collaboration.

St. Fox Expands Presence with New Office in Bengaluru to Boost Cybersecurity Innovation
Rutuparna Rath news
St. Fox Expands Presence with New Office in Bengaluru to Boost Cybersecurity Innovation

Bangalore, 24th January 2025 – St. Fox, a rapidly growing cybersecurity consultancy built on the principles of fearless innovation and relentless protection, is thrilled to open its new office in Bangalore. Headquartered in Pune, the company sets footprint in Bangalore marking its 2nd office in India. The 100-seater office premises at HSR Layout, Bangalore, will be primarily supporting its R&D and client delivery teams. The new office is designed with sustainability and employee’s well-being in mind, leveraging renewable energy sources and energy-efficient infrastructure. Adopting Green Building Practices, the workspace includes ergonomic setups, wellness zones, and collaboration hubs to foster productivity and innovation among the employees.

Ronak Maniar, Founder and Managing Director of St. Fox, said, “We are excited to open our new office in Bangalore, the hub for IT sector and one of the key businesses & talent market for us. As part of our long-term growth strategy, expanding into Bangalore will enable us to further accelerate our already rapidly growing business. We believe the most important challenge facing us today is the need to secure our rapidly expanding digital ecosystem while fostering innovation. With cyberattacks becoming more sophisticated and frequent, we aim to expand our offerings, particularly in areas like AI-driven security, blockchain integration, and advanced data protection. We are committed to ensuring that our solutions evolve alongside the rapidly changing technological landscape, enabling our clients to not only protect their digital assets but also leverage new technologies to drive growth.

With a current workforce of over 120 SMEs across India, St. Fox continues to strengthen its capabilities in cybersecurity consulting, AI innovation, and technical consulting. Aiming to expand its India team to over 300 employees by 2026, the company has partnered with premier institutions across to nurture cybersecurity and AI talent. To address the cybersecurity talent gap, St. Fox has invested in continuous learning and development programs to ensure the team remains at the forefront of industry trends and advancements. The training and mentorship program aims to cultivate the next generation of cybersecurity leaders.

St. Fox’s headquarters at Pune, spans over 7,000 sq. ft. at one of the premium IT parks and can accommodate over 200 employees. As part of its ambitious growth strategy, the organization plans to open offices in Hyderabad and Mumbai by 2026 to tap into regional talent and business. Additionally, client engagement centers are set to be launched later this year in Dubai and Singapore, enhancing international collaboration and expanding global operations.

Timely Surgery Transforms 11-Year-Old’s Life After Moyamoya
Bhumika Lenka health
Timely Surgery Transforms 11-Year-Old’s Life After Moyamoya

Bangalore, 24th January, 2025: In a compelling case that underscores the importance of early diagnosis and expert intervention, an 11-year-old boy from Devanahalli Taluk, overcame the challenges posed by Moyamoya disease—a rare cerebrovascular disorder often leading to continuous strokes. Known to have a prevalence rate of 0.35 to 0.94 per 100,000 people, mainly in the areas of Japan and Korea, Moyamoya disease manifests itself via gradual narrowing of arteries supplying blood to the brain. Arjun (name changed) experienced an episode of seizure a year back which was progressively followed by a decline in his ability to see and weakness on the left side of his body over the course of the year. A CT Angiogram at Aster Whitefield Hospital showed a “puff of smoke” appearance – a hallmark sign of Moyamoya disease, hence confirming the diagnosis.

This rare and unique disease mostly affects children around the age of 10 years and adults around the age of 40 years while progressing without warning, necessitating prompt and precise medical intervention. Moyamoya disease causes narrowing of key brain arteries, prompting the brain to form smaller compensatory blood vessels to meet its oxygen needs. These new vessels, however, are often insufficient, appearing as a “puff of smoke” in imaging scans. When the brain’s demand for blood outpaces the supply, patients experience strokes or other neurological events, as in Arjun’s case. Left untreated, Moyamoya can lead to recurring strokes, disability, and even death, making early diagnosis critical to altering the disease’s course.

Recognizing the immediacy of the situation, the medical team decided to go ahead with a Revascularization surgery. This is an intricate procedure but offers a reliable method to restore blood flow to the brain. The surgeons carefully isolated a scalp artery, called the superficial temporal artery (STA) and connected it to an artery in the brain, creating an anastomosis. This connection enabled blood from the STA to eventually supply the brain, circumventing the narrowed arteries and improving oxygen delivery. But, the surgery was not without its challenges. Revascularization demanded careful handling of delicate arteries. Isolating them and suturing these tiny vessels required flawless execution. Through the combined expertise of Dr. Swaroop Gopal, Group Director – Aster International Institute of Neurosciences and Spine Care, Aster Whitefield Hospital, Specializing in Vascular and Endo-Vascular Surgery and Dr. Suraj Gopal, Associate Consultant, Neurosurgery, Aster Whitefield Hospital the surgery was completed successfully.

The post-operative prognosis for this disease includes stabilization of the symptoms with continuous evaluation. Arjun was discharged two days after his surgery and has been scheduled for regular check-ups to monitor his condition as Moyamoya disease is known to be bilateral, that is, it affects both the sides of the brain. Hence, there is a possibility that revascularization procedures may be needed for the opposite side of the brain as well.

“Arjun is doing well now. After the diagnosis, a Digital Subtraction Angiography (DSA) was performed to evaluate issues with the blood flow. This involved inserting a catheter into the leg artery and guiding it to the brain’s blood vessels, utilizing high-quality X rays to image the blood vessels”, mentioned Dr. Swaroop Gopal, Group Director – Aster International Institute of Neurosciences and Spine Care, Aster Whitefield Hospital. “The whole revascularization procedure was done under a microscope”, he added.

Arjun’s family were kept informed of all the developments and treatment plans on a daily basis. The rarity of the case made it a challenge for them to understand the condition and the need for surgery. But considerable information, reassurance and support from the medical team provided the parents with emotional strength to face the situation. Throughout the whole process they remained hopeful and strong.

Dr. Suraj Gopal, Associate Consultant, Neurosurgery, Aster Whitefield Hospital, mentioned, “Moyamoya is a surgically treatable disease. Hence, it is very important for parents, guardians or family to not dismiss the symptoms as a typical paralysis or stroke. Early recognition of the symptoms is crucial for the diagnosis and subsequent treatment. Missing symptoms increases the risk of recurrence, with strokes becoming more severe and occurring in closer intervals.”

Arjun has completely recovered from the weakness that had affected the left side of his body along with partial improvement in his vision, as the bypass starts functioning several weeks after the surgery. With timely intervention, advanced surgical techniques, and compassionate support, Arjun’s future is now full of possibilities. The success of his treatment offers hope to other families facing similar diagnoses, showcasing how expert care and determination can change lives.

Agilus Diagnostics Launches India’s Fastest Genomic Testing for Myeloid Malignancies with 3-Day Turnaround
Rutuparna Rath business
Agilus Diagnostics Launches India’s Fastest Genomic Testing for Myeloid Malignancies with 3-Day Turnaround

24 January 2025: Agilus Diagnostics, India’s largest and most trusted diagnostic network, announces a ground-breaking achievement in genomic testing with its industry-leading 3-day turnaround time (TAT) for test results in myeloid malignancies.

The genomic testing market in India is experiencing rapid growth, driven by advancements in technology, increasing awareness, and the rising demand for personalized medicine. Currently valued at approximately USD 150 million, the market is projected to grow at a CAGR of over 15% in the next five years. Genomic testing is transforming cancer diagnostics by revolutionizing targeted therapy and personalized medicine. By providing actionable insights into an individual’s unique genetic profile, it enables clinicians to identify specific mutations, tailor treatment plans, and select therapies that offer the highest efficacy. As the future of cancer diagnostics, genomic testing empowers early detection, precise interventions, and better disease management, marking a significant shift in how cancer care is delivered. With these advancements, Agilus Diagnostics’ cutting-edge offerings place it at the forefront of this expanding market. By delivering unparalleled speed and precision, the company is well-positioned to capitalize on the growing demand for genomic testing in India, establishing itself as a leader in the space.

Next Generation Sequencing (NGS) is revolutionizing genetic testing by enabling precise, comprehensive analysis of genetic variations, empowering clinicians with actionable insights for personalized patient care. While genomic testing has traditionally been a lengthy process, often taking weeks to deliver results, Agilus Diagnostics has set a new benchmark by delivering individualized reports—meticulously crafted by expert molecular pathologists—in just three days (for myeloid malignancies). This rapid turnaround ensures faster clinical decision-making, ultimately improving patient outcomes and setting us apart as leaders in precision diagnostics.

The Myeloid Genomics Testing and Precision Assay is designed to offer faster, more precise insights into cancer and myeloid disorders. The Myeloid Genomics Testing covers 79 genes, including those linked to inherited risks, to detect key genetic changes like mutations and fusions. This enables personalized treatment recommendations for conditions like Acute Myeloid Leukemia (AML) and Myeloproliferative Neoplasms (MPN). Reports are reviewed by expert pathologists and include internationally recognized risk assessment tools and therapy suggestions tailored to the patient.

The Genomic Profiling Precision Assay provides comprehensive genomic profiling for cancers like lung, colon, breast, and melanoma by analyzing 50 critical genes. It identifies mutations, amplifications, and fusion genes, offering actionable insights for targeted treatments. With optimized panels for tissue and blood samples, the test ensures accurate results within 2 days for liquid biopsy samples and 7 days for tissue block samples, making it a powerful tool for precision medicine.

“Our 3-day genomic testing initiative for myeloid malignancies addresses one of the biggest challenges in precision oncology —Time. With this breakthrough, Agilus Diagnostics is not only setting a new industry standard but also transforming patient care by enabling faster diagnoses and treatment,” said Dr. Anand K, Managing Director & CEO of Agilus Diagnostics.

Currently, the labs in the genomic testing space often take up to 2 -3 weeks to deliver results for myeloid malignancies, which can delay critical clinical decisions. In contrast, Agilus Diagnostics’ rapid testing approach significantly shortens the diagnostic timeline, reducing hospital visits and enhancing the patient experience.

Driving Global Standards in Genomic Testing

Agilus Diagnostics’ commitment to speed and precision extends beyond technological advancements. The company ensures that every report is individualized, with expert molecular pathologists meticulously interpreting results. This personalized reporting approach ensures that physicians receive not just data but clinically actionable insights that support timely and effective patient management.

Agilus Diagnostics is setting new benchmarks in genomic testing, aligning with global standards in personalized medicine. The combination of advanced technology, rapid turnaround times, and expert oversight positions the company as a leader in precision diagnostics. By offering unparalleled speed, accuracy, and patient-focused care, Agilus Diagnostics reaffirms its commitment to bringing world-class diagnostic services to India.

“With our advanced genomic testing capabilities, we aim to provide clinicians with the tools they need to make timely, informed decisions. This not only improves outcomes but also sets a new benchmark for the healthcare industry in India,” added Dr. Anand K.